Táňa Fadrná

Táňa Fadrná

Auto-generated profile, based on publicly available information

Táňa Fadrná

Department of Neurosurgery, Comprehensive Stroke Center, University Hospital Ostrava, Ostrava, Czech Republic

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
DŠDavid Školoudík
David Školoudík
TFTáňa Fadrná
Táňa Fadrná
PBPetra Bártová
Petra Bártová
KLKateřina Langová
Kateřina Langová
PRPavel Ressner
Pavel Ressner
PKPetr Kaňnovský
Petr Kaňnovský

1 August 2010 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
DŠDavid Školoudík
David Školoudík
Roman HerzigRoman Herzig
Roman Herzig
TFTáňa Fadrná
Táňa Fadrná
MBMichal Bar
Michal Bar
PHPavel Hradílek
Pavel Hradílek
PKPetr Kaňovský
Petr Kaňovský
Aims Optic nerve sheath diameter (ONSD) enlargement is detectable in patients with increased intracranial pressure. The aim was to detect an enlargement of the ONSD using optic nerve sonography in patients with acute intracerebral haemorrhage (ICH) within 6 h of the onset of symptoms. Methods Thirty-one acute ICH patients, 15 age-matched acute ischaemic stroke patients and 16 age-matched healthy volunteers were enrolled consecutively in this prospective bi-centre observational study. All acute stroke patients underwent brain CT, optic nerve sonography and transcranial colour-coded duplex sonography (TCCS) at admission within 6 h of stroke onset. The ONSD both 3.0 and 12.0 mm behind the globe using optic nerve sonography were recorded and statistically evaluated, as were age, sex, haemorrhage volume and midline shift measured by CT, and blood flow velocities in both middle cerebral arteries using TCCS. Results In acute ICH patients, a significant enlargement of ONSD was detected (p2.5 cm3 was the relative ONSD enlargement of >0.66 mm (>21 %), with 90.3% accuracy and kappa coefficient 0.760 (95% CI 0.509 to 1.000). Conclusions Sonographically measured enlargement of the ONSD may already be detectable in the hyperacute stage of increased intracranial pressure.

1 August 2011 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
PDF file
MRMartin Roubec
Martin Roubec
MKMartin Kuliha
Martin Kuliha
TJTomáš Jonszta
Tomáš Jonszta
VPVaclav Prochazka
Vaclav Prochazka
TFTáňa Fadrná
Táňa Fadrná
DŠDavid Školoudík
David Školoudík
Objectives The aim of this retrospective study was to compare intracranial arterial stenosis in patients with stroke using 3 different methods: transcranial color‐coded duplex sonography, computed tomographic (CT) angiography, and digital subtraction angiography in a common clinical practice. Methods Sixty‐seven patients (47 male and 20 female; age range, 23–79 years; mean age ± SD, 62.0 ± 9.5 years) were enrolled in this study over 40 months. All patients underwent examinations of the intracranial arteries using transcranial color‐coded sonography, CT angiography, and digital subtraction angiography. Findings were divided into 4 groups: normal, mild stenosis (<50%), severe stenosis (50%–99%), and occlusion. Results Because of technical reasons or an insufficient bone window, 465 of 536 arterial segments in 67 patients were evaluated; 12 stenotic and 15 occluded segments were detected using digital subtraction angiography. The sensitivity, specificity, positive predictive value, and negative predictive value of transcranial color‐coded sonography and CT angiography in comparison with digital subtraction angiography as a reference standard were 88.9%, 94.8%, 51.1%, and 99.3% and 81.5%, 98.7%, 78.6%, and 98.6%, respectively. The agreement between transcranial color‐coded sonography and CT angiography was 93.8% (κ = 0.559); between transcranial color‐coded sonography and digital subtraction angiography, it was 93.9% (κ = 0.588); and between CT angiography and digital subtraction angiography, it was 96.6% (κ = 0.697). Conclusions Moderate agreement was found between CT angiography, transcranial color‐coded sonography, and digital subtraction angiography in the evaluation of intracranial stenosis. Computed tomographic angiography and digital subtraction angiography are sufficient for assessment of the diagnosis.

31 July 2007 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
DŠDavid Školoudík
David Školoudík
TFTáňa Fadrná
Táňa Fadrná
MBMichal Bar
Michal Bar
OZOlga Zapletalová
Olga Zapletalová
OZOndřej Zapletal
Ondřej Zapletal
PKPetr Kaňovský
Petr Kaňovský

1 July 2010 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
DŠDavid Školoudík
David Školoudík
TFTáňa Fadrná
Táňa Fadrná
MRMartin Roubec
Martin Roubec
MBMichal Bar
Michal Bar
OZOndřej Zapletal
Ondřej Zapletal
Roman HerzigRoman Herzig
Roman Herzig

17 January 2017 in Trials
Verified
Journal Article
Open access
PDF file
THTomáš Hrbáč
Tomáš Hrbáč
DNDavid Netuka
David Netuka
VNVladimir Nosal
Vladimir Nosal
PKPetra Kešnerová
Petra Kešnerová
ATAleš Tomek
Aleš Tomek
DŠDavid Školoudík
David Školoudík
Carotid endarterectomy (CEA) is a beneficial procedure for selected patients with an internal carotid artery (ICA) stenosis. Surgical risk of CEA varies from between 2 and 15%. The aim of the study is to demonstrate the safety and effectiveness of sonolysis (continual transcranial Doppler monitoring, TCD) using a 2-MHz diagnostic probe with maximal diagnostic energy on the reduction of the incidence of stroke, transient ischemic attack (TIA) and brain infarction detected using magnetic resonance imaging (MRI) by the activation of the endogenous fibrinolytic system during CEA. Design: a multicenter, randomized, double-blind, sham-controlled trial. Scope: international, multicenter trial for patients with at least 70% symptomatic or asymptomatic ICA stenosis undergoing CEA. Inclusion criteria: patients with symptomatic or asymptomatic ICA stenosis of at least 70% are candidates for CEA; a sufficient temporal bone window for TCD; aged 40–85 years, functionally independent; provision of signed informed consent. Randomization: consecutive patients will be assigned to the sonolysis or control (sham procedure) group by computer-generated 1:1 randomization. Prestudy calculations showed that a minimum of 704 patients in each group is needed to reach a significant difference with an alpha value of 0.05 (two-tailed) and a beta value of 0.8 assuming that 10% would be lost to follow-up or refuse to participate in the study (estimated 39 endpoints). Endpoints: the primary endpoint is the incidence of stroke or TIA during 30 days after CEA and the incidence of new ischemic lesions on brain MRI performed 24 h after CEA in the sonolysis and control groups. Secondary endpoints are occurrence of death, any stroke, or myocardial infarction within 30 days, changes in cognitive functions 1 year post procedure related to pretreatment scores, and number of new lesions and occurrence of new lesions ≥0.5 mL on post-procedural brain MRI. Analysis: descriptive statistics and linear/logistic multiple regression models will be performed. Clinical relevance will be measured as relative risk reduction, absolute risk reduction and the number needed to treat. Reduction of the periprocedural complications of CEA using sonolysis as a widely available and cheap method may significantly increase the safety of CEA and extend the indication criteria for CEA. ClinicalTrials.gov, NCT02398734 . Registered on 20 March 2015.